Implementation of multiple prevention interventions could potentially reduce multidrug-resistant organism infections in acute care hospitals, according to new findings published in the American ...
Infections caused by multidrug-resistant organisms (MDROs) have dramatically increased in all parts of the world in the past decade. Antibiotic resistance, or the “silent tsunami,” occurs when germs ...
A CDC statistic frequently used to illustrate the scope of the threat of antimicrobial resistance in the United States may be a significant underestimation of the true burden, researchers said.
A seismic demographic shift is afoot, with older adults expected to outnumber children by the year 2034 for the first time in U.S. history. This will result in higher demand for long-term care ...
Decolonization also decreased infection-related hospitalization among participating nursing homes by an adjusted 26.7% (95% CI 19.0%-34.5%) compared with ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the ...
A study published in Open Forum Infectious Diseases examined the association between infectious diseases consultations and death following multidrug-resistant organism infections. Researchers ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial ...
Healthy dogs and cats could be passing on multidrug-resistant organisms (MDROs; bacteria that resist treatment with more than one antibiotic) to their hospitalised owners, and likewise humans could be ...
Antiseptic soap and nasal decolonization can prevent infection and hospitalization among nursing home residents — a simple intervention more facilities should use, Susan Huang, MD, the medical ...
Washington University School of Medicine in St. Louis has become the first to treat a patient with recurrent urinary tract infections with RBX2660, a microbiota-based drug candidate developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback